Linguistic markers of anxiety and depression in Somatic Symptom and Related Disorders: Observational study of a digital intervention.

Anxiety Depression Digital health Natural Language Processing Pain Somatic Symptom and Related Disorders

Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 May 2024
Historique:
received: 02 05 2023
revised: 18 01 2024
accepted: 06 02 2024
pmc-release: 01 05 2025
medline: 11 3 2024
pubmed: 10 2 2024
entrez: 9 2 2024
Statut: ppublish

Résumé

Somatic Symptom and Related Disorders (SSRD), including chronic pain, result in frequent primary care visits, depression and anxiety symptoms, and diminished quality of life. Treatment access remains limited due to structural barriers and functional impairment. Digital delivery offers to improve access and enables transcript analysis via Natural Language Processing (NLP) to inform treatment. Therefore, we investigated asynchronous message-delivered SSRD treatment, and used NLP methods to identify symptom reduction markers from emotional valence. 173 individuals diagnosed with SSRD received interventions from licensed therapists via messaging 5 days/week for 8 weeks. Depression and anxiety symptoms were measured with the PHQ-9 and GAD-7 from baseline every three weeks. Symptoms trajectories were identified using unsupervised random forest clustering. Emotional valence expressed and use of emotional words were extracted from patients' de-identified transcripts, respectively using VADER and NCR Lexicon. Valence differences were examined using logistic regression. Two subpopulations were identified showing symptoms Improvement (n = 72; 41.62 %) and non-response (n = 101; 58.38 %). Improvement patients expressed more positive valence in the first week of treatment (OR = 1.84, CI: 1.12-3.02; p = .015) and were less likely to express negative valence by the end of treatment (OR = 0.05; CI: 0.30-0.83; p = .008). Non-response patients used more negative valence words, including pain. Findings were derived from observational data obtained during an ecological intervention, without the inclusion of a control group. NLP identified linguistic markers distinguishing changes in anxiety and depression symptoms over treatment. Digital interventions offer new forms of delivery and provide the opportunity to automatically collect data for linguistic analysis.

Sections du résumé

BACKGROUND BACKGROUND
Somatic Symptom and Related Disorders (SSRD), including chronic pain, result in frequent primary care visits, depression and anxiety symptoms, and diminished quality of life. Treatment access remains limited due to structural barriers and functional impairment. Digital delivery offers to improve access and enables transcript analysis via Natural Language Processing (NLP) to inform treatment. Therefore, we investigated asynchronous message-delivered SSRD treatment, and used NLP methods to identify symptom reduction markers from emotional valence.
METHODS METHODS
173 individuals diagnosed with SSRD received interventions from licensed therapists via messaging 5 days/week for 8 weeks. Depression and anxiety symptoms were measured with the PHQ-9 and GAD-7 from baseline every three weeks. Symptoms trajectories were identified using unsupervised random forest clustering. Emotional valence expressed and use of emotional words were extracted from patients' de-identified transcripts, respectively using VADER and NCR Lexicon. Valence differences were examined using logistic regression.
RESULTS RESULTS
Two subpopulations were identified showing symptoms Improvement (n = 72; 41.62 %) and non-response (n = 101; 58.38 %). Improvement patients expressed more positive valence in the first week of treatment (OR = 1.84, CI: 1.12-3.02; p = .015) and were less likely to express negative valence by the end of treatment (OR = 0.05; CI: 0.30-0.83; p = .008). Non-response patients used more negative valence words, including pain.
LIMITATIONS CONCLUSIONS
Findings were derived from observational data obtained during an ecological intervention, without the inclusion of a control group.
CONCLUSIONS CONCLUSIONS
NLP identified linguistic markers distinguishing changes in anxiety and depression symptoms over treatment. Digital interventions offer new forms of delivery and provide the opportunity to automatically collect data for linguistic analysis.

Identifiants

pubmed: 38336165
pii: S0165-0327(24)00321-5
doi: 10.1016/j.jad.2024.02.012
pmc: PMC10947071
mid: NIHMS1968371
pii:
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-137

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH134068
Pays : United States

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest TDH is an employee of the platform that provided the data examined in this study. Talkspace had no role in the analysis, interpretation of the data, or decision to submit the manuscript for publication.

Références

J Psychosom Res. 2018 Oct;113:74-80
pubmed: 30190052
J Med Internet Res. 2020 Jul 6;22(7):e16228
pubmed: 32628116
Proc Natl Acad Sci U S A. 2022 Mar 29;119(13):e2114737119
pubmed: 35316132
Cochrane Database Syst Rev. 2014 Nov 01;(11):CD011142
pubmed: 25362239
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Can J Psychiatry. 2015 Apr;60(4):160-7
pubmed: 26174215
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Transl Psychiatry. 2021 Apr 20;11(1):227
pubmed: 33879773
Transl Psychiatry. 2023 Oct 6;13(1):309
pubmed: 37798296
Nat Hum Behav. 2021 Apr;5(4):458-466
pubmed: 33574604
Int J Methods Psychiatr Res. 2003;12(1):34-43
pubmed: 12830308
BMC Psychiatry. 2020 Jun 12;20(1):297
pubmed: 32532225
Compr Psychiatry. 2019 Apr;90:88-94
pubmed: 30818088
Front Artif Intell. 2020 Jan 21;2:31
pubmed: 33733120
Int J Methods Psychiatr Res. 2014 Sep;23(3):289-303
pubmed: 24687693
J Med Internet Res. 2021 Jul 14;23(7):e28244
pubmed: 34259637
J Psychosom Res. 2016 Jan;80:1-10
pubmed: 26721541
J Clin Psychol. 2011 Sep;67(9):942-68
pubmed: 21647882

Auteurs

Matteo Malgaroli (M)

Department of Psychiatry, NYU Grossman School of Medicine, New York, NY 10016, USA. Electronic address: matteo.malgaroli@nyulangone.org.

Thomas D Hull (TD)

Research and Development, Talkspace, New York, NY 10023, USA.

Adam Calderon (A)

Department of Psychiatry, NYU Grossman School of Medicine, New York, NY 10016, USA; Department of Psychology, Pennsylvania State University, State College, PA 16801, USA.

Naomi M Simon (NM)

Department of Psychiatry, NYU Grossman School of Medicine, New York, NY 10016, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH